Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 6470

1.

2014 French guidelines for hepatitis B and C screening.A combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.

Bottero J, Brouard C, Roudot-Thoraval F, Deuffic-Burban S, Hofliger P, Abergel A, Volant J, Dhumeaux D, Yazdanpanah Y; Viral Hepatitis Testing Experts group.

Liver Int. 2016 Apr 4. doi: 10.1111/liv.13135. [Epub ahead of print]

PMID:
27043826
2.

Autoimmune hepatitis: a manifestation of immune reconstitution inflammatory syndrome in HIV infected patients?

Murunga E, Andersson M, Rensburg CV.

Scand J Gastroenterol. 2016 Mar 22:1-5. [Epub ahead of print]

PMID:
27000683
3.

[A needlestick injury - what next?].

Wicker S, Rabenau HF.

MMW Fortschr Med. 2015 Nov 5;157(19):49-50. German. No abstract available.

PMID:
26953410
4.

Evaluation of Drug-Drug Interactions between Direct-Acting Anti-Hepatitis C Virus Combination Regimens and the HIV-1 Antiretroviral Agents Raltegravir, Tenofovir, Emtricitabine, Efavirenz, and Rilpivirine.

Khatri A, Dutta S, Dunbar M, Podsadecki T, Trinh R, Awni W, Menon R.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2965-71. doi: 10.1128/AAC.02605-15. Print 2016 May.

PMID:
26953200
5.

Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.

Hsu DC, Sereti I.

Drugs. 2016 Apr;76(5):533-49. doi: 10.1007/s40265-016-0546-7.

PMID:
26915027
6.

Direct anti-HCV agents.

Zhang X.

Acta Pharm Sin B. 2016 Jan;6(1):26-31. doi: 10.1016/j.apsb.2015.09.008. Epub 2015 Nov 24. Review.

8.

Sequential Therapy with PEG-IFN alpha-2a and Tenofovir in a Hepatitis B Virus-Infected African Man.

Cainelli F, Vento S.

Isr Med Assoc J. 2015 Dec;17(12):790. No abstract available.

9.

Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.

Thenin-Houssier S, de Vera IM, Pedro-Rosa L, Brady A, Richard A, Konnick B, Opp S, Buffone C, Fuhrmann J, Kota S, Billack B, Pietka-Ottlik M, Tellinghuisen T, Choe H, Spicer T, Scampavia L, Diaz-Griffero F, Kojetin DJ, Valente ST.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2195-208. doi: 10.1128/AAC.02574-15. Print 2016 Apr.

PMID:
26810656
10.

[Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaoundé Central Hospital in the centre region of Cameroon].

Ankouane F, Noah Noah D, Atangana MM, Kamgaing Simo R, Guekam PR, Biwolé Sida M.

Transfus Clin Biol. 2016 Jan 11. pii: S1246-7820(15)00438-3. doi: 10.1016/j.tracli.2015.11.008. [Epub ahead of print] French.

PMID:
26791918
11.

[Hepatitis C genotype 1. Harvoni and Holkira Pak reimbursed?].

Sabourin G.

Perspect Infirm. 2015 Nov-Dec;12(5):60. French. No abstract available.

PMID:
26730433
12.

GENOMIC ANALYSIS OF HEPATITIS B VIRUS STRAINS INFECTING ROMANIAN PATIENTS.

Dinu S, Târdei G, Ceausu E, Moţoc A, Oprea C, Ungureanu E, Ene L, Duiculescu D, Cioflec DB, Oprişan G.

Roum Arch Microbiol Immunol. 2015 Jan-Jun;74(1-2):18-25.

PMID:
26727850
13.

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?

Mohr R, Schierwagen R, Schwarze-Zander C, Boesecke C, Wasmuth JC, Trebicka J, Rockstroh JK.

Medicine (Baltimore). 2015 Dec;94(50):e2127. doi: 10.1097/MD.0000000000002127.

14.

Treatment and disease outcomes of migrants from low- and middle-income countries in the Australian HIV Observational Database cohort.

Tilley DM, Griggs E, Hoy J, Wright ST, Woolley I, Burke M, O'Connor CC; Australian HIV Observational Database (AHOD).

AIDS Care. 2015;27(11):1410-7. doi: 10.1080/09540121.2015.1113227.

PMID:
26679270
15.

Evaluating patterns in retention, continuation, gaps, and re-engagement in HIV care in a Medicaid-insured population, 2006-2012, United States.

Byrd KK, Furtado M, Bush T, Gardner L.

AIDS Care. 2015;27(11):1387-95. doi: 10.1080/09540121.2015.1114991.

PMID:
26679267
16.

[Possibilities of IFN-free therapy of hepatitis C].

Husa P.

Vnitr Lek. 2015 Nov;61 Suppl 4:4s24-9. Review. Czech.

PMID:
26667617
17.

The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients.

Ziaee M, Namaei MH, Azarkar G.

Pak J Med Sci. 2015 Sep-Oct;31(5):1246-9. doi: 10.12669/pjms.315.7888.

18.

Screening for transfusion transmissible infections using rapid diagnostic tests in Africa: a potential hazard to blood safety?

Prugger C, Laperche S, Murphy EL, Bloch EM, Kaidarova Z, Tafflet M, Lefrère JJ, Jouven X.

Vox Sang. 2016 Feb;110(2):196-8. doi: 10.1111/vox.12327. Epub 2015 Dec 8.

PMID:
26646317
19.

Sustainable HIV treatment in Africa through viral-load-informed differentiated care.

Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa, Phillips A, Shroufi A, Vojnov L, Cohn J, Roberts T, Ellman T, Bonner K, Rousseau C, Garnett G, Cambiano V, Nakagawa F, Ford D, Bansi-Matharu L, Miners A, Lundgren JD, Eaton JW, Parkes-Ratanshi R, Katz Z, Maman D, Ford N, Vitoria M, Doherty M, Dowdy D, Nichols B, Murtagh M, Wareham M, Palamountain KM, Chakanyuka Musanhu C, Stevens W, Katzenstein D, Ciaranello A, Barnabas R, Braithwaite RS, Bendavid E, Nathoo KJ, van de Vijver D, Wilson DP, Holmes C, Bershteyn A, Walker S, Raizes E, Jani I, Nelson LJ, Peeling R, Terris-Prestholt F, Murungu J, Mutasa-Apollo T, Hallett TB, Revill P.

Nature. 2015 Dec 3;528(7580):S68-76. doi: 10.1038/nature16046.

PMID:
26633768
20.

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015.

Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Sarin SK, Singh SP, Chawla YK, Aggarwal R, Amarapurkar D, Arora A, Dixit VK, Sood A, Shah S, Duseja A, Kapoor D, Shalimar, Madan K, Pande G, Nagral A, Kar P, Koshy A, Puri AS, Eapen CE, Thareja S.

J Clin Exp Hepatol. 2015 Sep;5(3):221-38. doi: 10.1016/j.jceh.2015.09.002. Epub 2015 Sep 21. Review.

PMID:
26628840
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk